Source link : https://newshealth.biz/health-news/novo-nordisk-ends-lawsuit-collaborates-with-hims-hers-to-sell-semaglutide/
Novo Nordisk is dismissing its patent infringement lawsuit against telehealth company Hims & Hers, as the two companies have reached an agreement that will see branded semaglutide (Ozempic, Wegovy) products sold through the Hims platform. Early last month, Hims & Hers said that it was going to launch a cheaper, compounded semaglutide pill for weight […]
The post Novo Nordisk Ends Lawsuit, Collaborates With Hims & Hers to Sell Semaglutide first appeared on News Health.
—-
Author : News Health
Publish date : 2026-03-09 15:36:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8